CASP8 and glioblastoma: The Kaplan–Meier analysis revealed that a higher expression of CDK2 (Figure 5a), BAX (Figure 5e), and CASP8 (Figure 5f) genes is associated with a decreased median survival in GBM patients, which suggests that these genes/proteins may have negative prognostic values in GBM.